Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

A review of COVID-19 data from the UK shows that patients with rare autoimmune rheumatic disease (RAIRD) face a higher mortality risk, according to an article in Healio. The study,…

Continue Reading Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

Researchers Find Hypothyroidism is Linked to ANCA-Associated Vasculitis

The American College of Rheumatology presented new findings on November 5, 2020 at their virtual conference. They found that in patients with ANCA-associated vasculitis (AAV), hypothyroidism is associated with positive…

Continue Reading Researchers Find Hypothyroidism is Linked to ANCA-Associated Vasculitis
Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission
source: pixabay.com

Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission

According to a story from ANCA Vasculitis News, a recent study has determined that monitoring changes in autoantibodies targeting the PR3 protein is useful for predicting ANCA vasculitis remission after…

Continue Reading Changes to ANCA Vasculitis Autoantibodies Can Predict Relapse and Remission
Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19
source: pixabay.com

Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Michael George and his team from the University of Pennsylvania have recently uncovered new insights regarding autoimmune patient’s comfortability with care during COVID-19. They've been working since the pandemic began…

Continue Reading Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19
Avacopan Better than Prednisone for Patients with AAV, Study Shares
freegr / Pixabay

Avacopan Better than Prednisone for Patients with AAV, Study Shares

Recently, the American College of Rheumatology (ACR) virtually held ACR Convergence 2020, the organization's annual meeting. At the meeting, researchers shared new insights in the realm of rheumatology; these were…

Continue Reading Avacopan Better than Prednisone for Patients with AAV, Study Shares
EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis
source: pixabay.com

EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis

On November 3, 2020, biopharmaceutical company ChemoCentryx and global pharmaceutical company Vifor Pharma Group's sub-business Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced that the European Medicines Agency will review…

Continue Reading EMA Approves MAA Review of Avacopan for ANCA-Associated Vasculitis
Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
source: pixabay.com

Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse

In a recent study published in Clinical and Experimental Immunology, researchers determined that patients with high ANCA antibody levels are at an increased risk of having ANCA-associated vasculitis (AAV) relapses. According…

Continue Reading Patients with High ANCA Antibody Levels Have Greater Risk of AAV Relapse
 Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
source: pixabay.com

 Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations

Dr. Jasvinder Singh, a rheumatologist at Alabama’s University in Birmingham is the author of a study that was featured in Arthritis Care and Research. During a recent interview with MedPageToday,…

Continue Reading  Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
source: pixabay.com

New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment

ChemoCentryx has just announced that they have submitted their New Drug Application to the FDA for a novel ANCA-associated vasculitis therapy. It is called avacopan and it's finally something non-steroidal.…

Continue Reading New Drug Application Submitted for Non-Steroidal ANCA-Associated Vasculitis Treatment
MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

MRFF Funding Promotes Treatment Development for Patients with Rare Diseases

  When it comes to researching and finding treatments for rare diseases, funding plays a crucial role. Recently, the Medical Research Future Fund (MRFF) Stem Cell Therapies Mission presented Monash…

Continue Reading MRFF Funding Promotes Treatment Development for Patients with Rare Diseases
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
ANCA Vasculitis Could Be Severe Complication of Lemtrada
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

ANCA Vasculitis Could Be Severe Complication of Lemtrada

According to ANCA Vasculitis News, recent research shows that patients with multiple sclerosis who are being treated with Lemtrada are at greater risk of developing severe ANCA vasculitis. The drug therapy…

Continue Reading ANCA Vasculitis Could Be Severe Complication of Lemtrada